Literature DB >> 27586081

A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice.

Michael F Bode1, Nigel Mackman2.   

Abstract

INTRODUCTION: Mice with a complete absence of tissue factor (TF) die during embryonic development whereas mice with low levels of TF (Low-TF mice) survive to adulthood. Low-TF mice exhibit spontaneous hemorrhage in various organs, including the lung. In contrast, mice can survive without protease-activated receptor (PAR)-4, which is the major thrombin receptor on mouse platelets. We determined the effect of combining a deficiency PAR-4 (primary hemostasis) with a deficiency in TF (secondary hemostasis) on embryonic development and survival of adult mice.
MATERIALS AND METHODS: Low-TF mice (mTF-/-, hTF+/+) were crossed with PAR-4-/- mice to generate heterozygous mice (mTF+/-, hTF+/-, PAR-4+/-). These mice were intercrossed to generate Low-TF mice lacking PAR-4. Mice surviving to wean were genotyped and survival was monitored for 6months.
RESULTS: We observed the expected number of Low-TF,PAR-4-/- mice at wean indicating survival in utero and after birth. However, an absence of PAR-4 was associated with premature death of all Low-TF,PAR-4-/- mice in the 6month observational period. This compares with 40% death of the Low-TF,PAR-4+/+ mice (p=0.003). Low-TF,PAR-4+/- mice had an intermediate phenotype with 55% of the mice dying within 6months. The primary cause of mortality of Low-TF,PAR-4-/- mice was pulmonary hemorrhage.
CONCLUSIONS: Low-TF,PAR-4-/- mice survive into adulthood, but combining a deficiency of primary hemostasis (PAR-4 deficiency) with secondary hemostasis (low levels of TF) leads to premature death primarily due to pulmonary hemorrhage.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hemostasis; Platelet; Pulmonary hemorrhage; Transgenic mice

Mesh:

Substances:

Year:  2016        PMID: 27586081      PMCID: PMC5061619          DOI: 10.1016/j.thromres.2016.08.023

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  35 in total

1.  Rivaroxaban in patients with a recent acute coronary syndrome.

Authors:  Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson
Journal:  N Engl J Med       Date:  2011-11-13       Impact factor: 91.245

2.  Role of tissue factor in embryonic blood vessel development.

Authors:  P Carmeliet; N Mackman; L Moons; T Luther; P Gressens; I Van Vlaenderen; H Demunck; M Kasper; G Breier; P Evrard; M Müller; W Risau; T Edgington; D Collen
Journal:  Nature       Date:  1996-09-05       Impact factor: 49.962

3.  Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.

Authors:  M Dewerchin; Z Liang; L Moons; P Carmeliet; F J Castellino; D Collen; E D Rosen
Journal:  Thromb Haemost       Date:  2000-02       Impact factor: 5.249

4.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Authors:  H Weiler-Guettler; P D Christie; D L Beeler; A M Healy; W W Hancock; H Rayburn; J M Edelberg; R D Rosenberg
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 5.  Tissue-specific hemostasis in mice.

Authors:  Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

Review 6.  Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice.

Authors:  Rafal Pawlinski; Brian Pedersen; Jonathan Erlich; Nigel Mackman
Journal:  Thromb Haemost       Date:  2004-09       Impact factor: 5.249

7.  Role of cardiac myocyte tissue factor in heart hemostasis.

Authors:  R Pawlinski; M Tencati; T Holscher; B Pedersen; T Voet; R E Tilley; P Marynen; N Mackman
Journal:  J Thromb Haemost       Date:  2007-08       Impact factor: 5.824

8.  Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets.

Authors:  J R Hamilton; I Cornelissen; S R Coughlin
Journal:  J Thromb Haemost       Date:  2004-08       Impact factor: 5.824

9.  Prothrombin deficiency results in embryonic and neonatal lethality in mice.

Authors:  W Y Sun; D P Witte; J L Degen; M C Colbert; M C Burkart; K Holmbäck; Q Xiao; T H Bugge; S J Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Incomplete embryonic lethality and fatal neonatal hemorrhage caused by prothrombin deficiency in mice.

Authors:  J Xue; Q Wu; L A Westfield; E A Tuley; D Lu; Q Zhang; K Shim; X Zheng; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more
  3 in total

1.  Murine tissue factor disulfide mutation causes a bleeding phenotype with sex specific organ pathology and lethality.

Authors:  Susanna H M Sluka; Simon F Stämpfli; Alexander Akhmedov; Tanja Klein-Rodewald; Adrián Sanz-Moreno; Marion Horsch; Paula Grest; Andrea S Rothmeier; Birgit Rathkolb; Anja Schrewe; Johannes Beckers; Frauke Neff; Eckhard Wolf; Giovanni G Camici; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Thomas F Lüscher; Wolfram Ruf; Felix C Tanner
Journal:  Haematologica       Date:  2019-09-05       Impact factor: 9.941

2.  Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor.

Authors:  Steven P Grover; Clare M Schmedes; Alyson C Auriemma; Emily Butler; Molly L Parrish; Adam Miszta; Audrey C Cleuren; Mayken Visser; Stefan Heitmeier; Jens J Posma; Henri M Spronk; Silvio Antoniak; Alisa S Wolberg; Rafal Pawlinski; David Gailani; Nigel Mackman
Journal:  Blood Adv       Date:  2020-01-14

3.  A coagulation defect arising from heterozygous premature termination of tissue factor.

Authors:  Sol Schulman; Emale El-Darzi; Mary Hc Florido; Max Friesen; Glenn Merrill-Skoloff; Marisa A Brake; Calvin R Schuster; Lin Lin; Randal J Westrick; Chad A Cowan; Robert Flaumenhaft; Willem H Ouwehand; Kathelijne Peerlinck; Kathleen Freson; Ernest Turro; Bruce Furie
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.